Joshua S. Boger

Joshua S. Boger discloses dealings in 2 companies, chiefly Vertex Pharmaceuticals INC / MA and CervoMed Inc. Between 30 December 2015 and 11 June 2026, the trades on record add up to 45 filings.

Market trades split into 1 purchase and 36 sales. No amount is published for 37 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 7 option exercises. So far in 2026, the count stands at 1 purchase and no sales.

Most recently, on 15 June 2026, the filings show an open-market purchase in CervoMed Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.